Drug Evaluation during the Covid-19 Pandemic

N Engl J Med. 2020 Jun 11;382(24):2282-2284. doi: 10.1056/NEJMp2009457. Epub 2020 Apr 14.
No abstract available

MeSH terms

  • Betacoronavirus
  • Chloroquine / supply & distribution
  • Chloroquine / therapeutic use
  • Clinical Trials as Topic
  • Coronavirus Infections / drug therapy*
  • Drug Approval*
  • Drug Evaluation / standards*
  • Drugs, Investigational / therapeutic use
  • Humans
  • Hydroxychloroquine / supply & distribution
  • Hydroxychloroquine / therapeutic use
  • Off-Label Use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • United States
  • United States Food and Drug Administration

Substances

  • Drugs, Investigational
  • Hydroxychloroquine
  • Chloroquine

Supplementary concepts

  • COVID-19
  • COVID-19 drug treatment
  • severe acute respiratory syndrome coronavirus 2